4.8 Article

NMNAT1 mutations cause Leber congenital amaurosis

期刊

NATURE GENETICS
卷 44, 期 9, 页码 1040-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2361

关键词

-

资金

  1. US National Institutes of Health [RO1-EY12910, R03-DK082446, R01-GM097409, P30HD026979, P30EY014104]
  2. Foundation Fighting Blindness USA
  3. Rosanne Silbermann Foundation
  4. Penn Genome Frontiers Institute
  5. Loyola University Stritch School of Medicine
  6. Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia
  7. Clinical and Translational Research Center at the Children's Hospital of Philadelphia [UL1-RR-024134]
  8. Department of Biotechnology, the Government of India
  9. Champalimaud Foundation, Portugal
  10. Hyderabad Eye Research Foundation
  11. Council for Scientific and Industrial Research
  12. Foundation Voir et Entendre, Ville de Paris and Region Ille de France
  13. RP Fighting Blindness (UK)
  14. Fight For Sight (UK)
  15. Moorfields Eye Hospital National Institute of Health Research (NIHR) British Research Council (BRC) for Ophthalmology
  16. Special Trustees of Moorfields Eye Hospital
  17. Penn Genome Frontiers Institute under Pennsylvania Department of Health

向作者/读者索取更多资源

Leber congenital amaurosis (LCA) is an infantile-onset form of inherited retinal degeneration characterized by severe vision loss(1,2). Two-thirds of LCA cases are caused by mutations in 17 known disease-associated genes(3) (Retinal Information Network (RetNet)). Using exome sequencing we identified a homozygous missense mutation (c.25G> A, p.Val9Met) in NMNAT1 that is likely to be disease causing in two siblings of a consanguineous Pakistani kindred affected by LCA. This mutation segregated with disease in the kindred, including in three other children with LCA. NMNAT1 resides in the previously identified LCA9 locus and encodes the nuclear isoform of nicotinamide mononucleotide adenylyltransferase, a rate-limiting enzyme in nicotinamide adenine dinucleotide (NAD(+)) biosynthesis(4,5). Functional studies showed that the p.Val9Met alteration decreased NMNAT1 enzyme activity. Sequencing NMNAT1 in 284 unrelated families with LCA identified 14 rare mutations in 13 additional affected individuals. These results are the first to link an NMNAT isoform to disease in humans and indicate that NMNAT1 mutations cause LCA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据